Skip to content

Clinical trials

Phase 3 Arterial Occlusive Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arterial Occlusive Diseases Phase: Phase 3 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20051
20061
20082
20091
20111
20121
20161
20171
20182
20192
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated5
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARCA Biopharma, Inc.2
Beijing Northland Biotech. Co., Ltd.2
Boston Scientific Corporation2
National Heart, Lung, and Blood Institute (NHLBI)2
Abiomed Inc.1
Amarin Pharma Inc.1
GE Healthcare1
Hermina Heart Center Kemayoran1
Johns Hopkins University1
Lantheus Medical Imaging1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arterial Occlusive Diseases22
Heart Diseases6
Ischemia6
Intermittent Claudication5
Vascular Diseases5
Arteriosclerosis4
Cardiovascular Diseases4
Coronary Artery Disease4
Coronary Disease4
Myocardial Ischemia4

Trials

Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.